Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/26 19:18 | 9/15/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Goncalves Joana | CA | O | Chief Me | 3 | S.d | -2,121 | 96.64 | 0 | -22 | 33 | D | |||||||||||||||
9/15/26 19:17 | 9/11/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Agarwal Arjun | CA | O | SVP,Fina | 3 | S.dm | -2,839 | 94.57 | 0 | -30 | 15 | D | |||||||||||||||
9/15/26 19:15 | 9/15/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Klein Lawrence Otto | CA | DO | CEO | 2 | S.d | -7,122 | 91.96 | 0 | -77 | 926 | D | |||||||||||||||
9/15/26 19:14 | 9/15/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Quinlan Paul T | CA | O | GC | 2 | S.d | -5,741 | 108.24 | 0 | -53 | 31 | D | |||||||||||||||
9/15/26 19:11 | 9/15/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Sandler Laura Lee | CA | O | COO | 3 | S.d | -1,018 | 93.33 | 0 | -11 | 236 | D | |||||||||||||||
7/1/26 21:30 | 7/1/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | DT | 1 | S.d | -300,014 | 84.43 | 0 | -3,553 | 3,705 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |